about
GlcNAcylation of histone H2B facilitates its monoubiquitinationDigital quantification of gene expression in sequential breast cancer biopsies reveals activation of an immune responseEZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent.Refined DNase-seq protocol and data analysis reveals intrinsic bias in transcription factor footprint identification.High-dimensional genomic data bias correction and data integration using MANCIEBINOCh: binding inference from nucleosome occupancy changes.8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC.Nucleosome dynamics define transcriptional enhancers.Systematic evaluation of factors influencing ChIP-seq fidelityDifferentiation-specific histone modifications reveal dynamic chromatin interactions and partners for the intestinal transcription factor CDX2Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1.PLZF, a tumor suppressor genetically lost in metastatic castration-resistant prostate cancer, is a mediator of resistance to androgen deprivation therapy.Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics.ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancerResponse and resistance to BET bromodomain inhibitors in triple-negative breast cancerModeling cis-regulation with a compendium of genome-wide histone H3K27ac profiles.K48-linked KLF4 ubiquitination by E3 ligase Mule controls T-cell proliferation and cell cycle progression.Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer.Lysine-specific demethylase 1 has dual functions as a major regulator of androgen receptor transcriptional activity.MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A.Transcriptional landscape of the human cell cycle.Variant Set Enrichment: an R package to identify disease-associated functional genomic regions.Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein.LSD1-Mediated Epigenetic Reprogramming Drives CENPE Expression and Prostate Cancer Progression.Reactivation of androgen receptor-regulated lipid biosynthesis drives the progression of castration-resistant prostate cancer.Genomic hallmarks of localized, non-indolent prostate cancer.Crucial role of noncoding RNA in driving prostate cancer development and progression.Noncoding RNA for personalized prostate cancer treatment: utilizing the 'dark matters' of the genome.Refined RIP-seq protocol for epitranscriptome analysis with low input materialsONECUT2 is a driver of neuroendocrine prostate cancerN6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesisTMPRSS2-ERG activates NO-cGMP signaling in prostate cancer cellsGastrointestinal transcription factors drive lineage-specific developmental programs in organ specification and cancerEarly-life programming of mesenteric lymph node stromal cell identity by the lymphotoxin pathway regulates adult mucosal immunity
P50
Q28254074-36DD14D7-3784-47F3-BE03-2F2667645F26Q28533543-430F8849-7359-4B49-88D8-A668367B0FC3Q30538848-2224B2A2-7896-44BA-9466-979771A9A7E6Q30710808-F0F65060-E248-46C7-B18A-C17E798EF81FQ31075558-72FDB0B6-A239-47EA-8E58-E55D4192EB29Q33892104-E6F44B3A-FF16-4346-8A2C-8348B83F65AAQ34006369-62D0033B-F3E8-4136-A67D-8A3C27E2FEB8Q34099759-D5BFA3E7-7E3D-4596-85CA-B08896D0C924Q34241267-2125807B-1B0F-4C92-98FD-8385F7F6B9D8Q34404177-8C260745-D125-467F-9CB8-ED3265ECD506Q35575633-CFA4CDDE-1DF1-48A7-A88D-1D2449AE46D4Q35612095-4D934E26-08CE-48A7-8254-33ED86856822Q36021732-78E15487-9729-438D-8CA2-0A73CC18CF58Q36638207-15F7EBE8-5F83-41D5-BDA8-0B243A7F1F16Q36862936-8FA15672-E855-452C-96CB-A7E09F734B68Q37313704-7FF552E6-C655-4433-B170-1E8DF97B8217Q37591368-698107C9-2C48-4630-BAB1-BB1FFC2D04B6Q38727020-5940BF16-45DF-4A33-8C93-3663EBB7EEE5Q38751776-CFAE22E7-6CAD-49BC-BECF-66148AC23A55Q38931537-B1933C6F-7340-45A7-A4E3-C98BF36D4E81Q39139064-970E987C-888E-46FD-B3A0-E8914D33A609Q41678024-6BB699DD-A310-42B5-996F-9B02E5675A08Q42098809-5E585FCD-6C4E-4E65-9ABD-9F9C4B6FBBCFQ42363301-80D9092D-F23E-44DD-9346-18B24F2C7504Q44020966-611C5433-5E2D-4D3D-847E-F42AAF1CA8FFQ50068799-915BFF4D-BD1D-463F-9639-4E4BE5C28D19Q50211176-64B5A241-0A2D-4ED1-9B7C-B4F5E4EA0296Q52426413-6FCB71D5-2323-424C-94D5-B0A7ACB86799Q53682665-5E72A447-12F9-4CE7-AAE0-4F0C959B3E75Q58744485-19C06009-FE79-41E6-A679-EC0FB5597390Q60907546-37E78473-1D34-4573-840A-7F7C4E638394Q90639985-84AF55B6-31B7-455F-99EE-A04113EE192DQ91341634-B22FCFB8-1F96-429B-939F-A38CBFBF9DDFQ92028996-A0851415-BE57-4CDB-9C63-0899C3D26C47Q92162653-B87039BC-093D-4230-8906-1CAB76068F56
P50
description
researcher ORCID ID = 0000-0003-2898-3363
@en
wetenschapper
@nl
name
Housheng Hansen He
@ast
Housheng Hansen He
@en
Housheng Hansen He
@es
Housheng Hansen He
@nl
type
label
Housheng Hansen He
@ast
Housheng Hansen He
@en
Housheng Hansen He
@es
Housheng Hansen He
@nl
prefLabel
Housheng Hansen He
@ast
Housheng Hansen He
@en
Housheng Hansen He
@es
Housheng Hansen He
@nl
P106
P1153
35995538800
P31
P496
0000-0003-2898-3363